Bachmann Bundle Pacing Combined with ICD in Hypertrophic Cardiomyopathy with Interatrial Conduction Block

Shengjie Wu1, Kelly Q Jia2, Xiangxiang Shi1

  • 1Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Nanbaixiang, Wenzhou, 325000, People's Republic of China.

Insights

This study shows Bachmann bundle pacing (BBP) with an implantable cardioverter-defibrillator (ICD) effectively treats hypertrophic cardiomyopathy (HCM) patients with interatrial conduction delay. BBP improved heart function and reduced heart failure symptoms.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Heart Failure Management

Background:

  • Familial hypertrophic cardiomyopathy (HCM) can cause severe heart failure and interatrial conduction delay (IACD).
  • Standard cardiac resynchronization therapy may be unsuitable for some HCM patients due to specific ventricular activation patterns.
  • Optimizing atrial synchrony is crucial for improving cardiac function in these patients.

Purpose of the Study:

  • To evaluate the efficacy of Bachmann bundle pacing (BBP) combined with a dual-chamber implantable cardioverter-defibrillator (ICD) in a patient with HCM, severe heart failure, and IACD.
  • To assess the impact of BBP on interatrial synchrony, left ventricular ejection fraction (LVEF), and New York Heart Association (NYHA) functional class.
  • To explore BBP as a novel therapeutic strategy for managing complex cardiac conditions in HCM.

Main Methods:

  • A 67-year-old male patient with HCM, LVEF 31%, NYHA III, and IACD underwent implantation of a dual-chamber ICD.
  • The atrial lead was positioned using Bachmann bundle pacing (BBP) to enhance interatrial synchrony.
  • Clinical status, echocardiographic parameters, and P-wave characteristics were monitored post-implantation.

Main Results:

  • Bachmann bundle pacing successfully corrected the interatrial conduction delay, evidenced by P-wave shortening and normalization.
  • Within one month, the patient showed significant clinical improvement: LVEF increased from 31% to 49%, and NYHA class improved from III to II.
  • Echocardiography demonstrated improved left atrial-left ventricular coupling, indicating enhanced cardiac efficiency.

Conclusions:

  • The combination of BBP and ICD provides a novel and effective treatment for HCM patients suffering from IACD.
  • This strategy offers dual benefits: protection against sudden cardiac death and substantial hemodynamic and functional improvements.
  • Optimizing atrial activation and atrioventricular synchrony through BBP is key to achieving these positive outcomes in challenging cardiac cases.

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Conduction System of the Heart01:19

Conduction System of the Heart

Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...